SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-038310
Filing Date
2023-02-14
Accepted
2023-02-14 13:00:53
Documents
1
Group Members
FLAGSHIP V VENTURELABS RX FUND, L.P.FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLCFLAGSHIP VENTURES FUND IV, L.P.FLAGSHIP VENTURES FUND IV-RX, L.P.FLAGSHIP VENTURES FUND V GENERAL PARTNER LLCFLAGSHIP VENTURES FUND V, L.P.FLAGSHIP VENTURES OPPORTUNITIES FUN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d439009dsc13ga.htm SC 13G/A 158662
  Complete submission text file 0001193125-23-038310.txt   160744
Mailing Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02143
Business Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02143 617-868-1888
Flagship VentureLabs IV, LLC (Filed by) CIK: 0001642578 (see all company filings)

IRS No.: 461974736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-679-9600
Rubius Therapeutics, Inc. (Subject) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90775 | Film No.: 23626052
SIC: 2836 Biological Products, (No Diagnostic Substances)